ACRV
NASDAQ
$1.74
Acrivon Therapeutics Inc (ACRV)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$74M
P/B Ratio
0.96
Free Cash Flow Yield
-89.11%
Price Chart
Valuation
Market Cap$74M
P/B0.96
Profitability
EBITDA-$81M
EPS-$2.34
Financial Health
Free Cash Flow Yield-89.11%
Growth & Risk
Sharpe Ratio0.72